Patent details

Basic Information

Publication number:

EP3521282

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP182133090

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

QUINAZOLINE DERIVATIVES USED TO TREAT HIV

French Title of Invention:

DÉRIVÉS DE QUINAZOLINE UTILISÉS POUR TRAITER LE VIH

German Title of Invention:

CHINAZOLINDERIVATE ZUR BEHANDLUNG VON HIV

SPC Number:

Dates

Filing date:

23/12/2015

Grant date:

25/08/2021

EP Publication Date:

07/08/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/08/2021

EP B1 Publication Date:

25/08/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

23/12/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/08/2021

 

 

Name:

Gilead Sciences, Inc.

Address:

333 Lakeside Drive, Foster City, CA 94404, United States (US)

Name:

Institute of Organic Chemistry and Biochemistry AS CR, V.V.I.

Address:

Flemingovo nam. 2, 16610 Praha 6, Czech Republic (CZ)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

26/08/2021

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

BASZCZYNSKI, Ondrej

Address:

Czech Republic (CZ)

2

Name:

LANSDON, Eric

Address:

United States (US)

3

Name:

MACKMAN, Richard, L.

Address:

United States (US)

4

Name:

SIMON, Petr

Address:

Czech Republic (CZ)

5

Name:

HU, Yunfeng Eric

Address:

United States (US)

6

Name:

DEJMEK, Milan

Address:

Czech Republic (CZ)

7

Name:

JANSA, Petr

Address:

United States (US)

Priority

Priority Number:

201462096748 P

Priority Date:

24/12/2014

Priority Country:

United States (US)

Classification

IPC classification:

C07D 401/12; C07D 239/94; A61K 31/517; A61P 31/18;

Publication

European Patent Bulletin

1

Issue number:

202134

Publication date:

25/08/2021

Description:

Grant (B1)

2

Issue number:

202135

Publication date:

01/09/2021

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

31/12/2026

Annual Fee Number:

12

Annual Fee Amount:

165 Euro

Expected Payer:

Last Annual Fee Payment Date:

15/12/2025

Last Annual Fee Paid Number:

11

Last Annual Fee Paid Amount:

148 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
27/08/2021	Outgoing Correspondence	1
26/08/2021	Power Of Attorney	1